Intelligence / Healthtech / PMA Approvals / Abbott Vascular (Idef Technologies INC)
Approvalsdevice change approved (PMA)6 Nov 2026
Abbott Vascular (Idef Technologies INC)
6 Nov 2026: Device change approved (PMA) · Supera Peripheral Stent System. Recorded in the openFDA device PMA data.
- Decided
- 6 Nov 2026
- Device
- Supera Peripheral Stent System
- Specialty
- Cardiovascular
- Type
- Supplement (Special (Immediate Track))
- Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Reference
- P120020 S037
- Location
- Santa Clara, CA
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Abbott Vascular (Idef Technologies INC)
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Cardiovascular
PMA Approvals
6 NovMedalliance, LLCdevice change approved (PMA) · SELUTION SLR 014 PTCA Drug-Eluting BalloonApprovals5 NovAbbott Medicaldevice change approved (PMA) · UltiSynq Defibrillation lead; SurGrip Suture Sleeve AccessoryApprovals4 NovContego Medical, INC.device change approved (PMA) · Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic ProtectionApprovals4 NovMedtronic Cardiac Rhythm Disease Managementdevice change approved (PMA) · Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Crome MApprovals4 NovMedtronic Cardiac Rhythm Disease Managementdevice change approved (PMA) · Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI IApprovals30 OctMedtronic Vascular, INC.device change approved (PMA) · Abre Venous Self-expanding Stent SystemApprovals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.